downloading FTI Forming Suite 2023.2.0.1686059814

To register for the webcast, please clickĪgenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. Todd Yancey, M.D., Senior Advisor, Agenus Steven O’Day, M.D., Chief Medical Officer, Agenus Pashtoon Kasi, M.D., M.S., Weill Cornell Medicineīreelyn Wilky, M.D., University of Colorado Medicine Manuel Hidalgo, M.D., Ph.D., Weill Cornell Medicine

A live webcast of the event will be available.Īlexander Eggermont, M.D., Ph.D., University Medical Center, Utrecht, Princess Maxima Center for Pediatric Oncology, Comprehensive Cancer Center

Agenus will provide updates from the ongoing BOT/BAL clinical program, including in neoadjuvant colorectal cancer and pancreatic cancer. (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced that the Company will host a corporate event to discuss advancements in its botensilimab/balstilimab (BOT/BAL) program at the upcoming European Society for Medical Oncology (ESMO) Conference on Sunday, October 22, 2023.

Downloading FTI Forming Suite 2023.2.0.1686059814